An Interview with AZBio President and CEO on Life Sciences M&A in Arizona

Recently, PULSE had a conversation with Joan Koerber-Walker, president and CEO of AZBio, which recently celebrated 20 years of supporting the growth of Arizona’s life science industry. Joan, who has led AZBio since 2011, has a vested interest in making Arizona a place where bioscience organizations can thrive and find success, while supporting economic growth at the local and state level. PULSE asked Joan for her perspective on how mergers and acquisitions (M&A) have impacted and benefited Arizona’s economic outlook and contributions to the state.

Continue reading

Patients will lose access to 40% of future medicines because of the IRA, new research finds.

New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas. The effects of the IRA will have a far more serious impact on the development of new medicines than has been reported, according to the research.Continue reading

KOL Conversation: The Impact of the IRA on Oncology Patient Care

Impact of the IRA on Oncology Patient Care features an interview with Dr. Barbara L. McAneny, MD, FASCO, MACP Former President for the American Medical Association and the New Mexico Medical Society (NMMS); and currently CEO, New Mexico Cancer Center.

With Dr. Steve Potts CEO, Anticipate Bioscience.

Impact of the IRA on Oncology Patient Care was recorded on the 26th of May 2023Continue reading

How You Can Impact Arizona’s Innovation Future

Grass roots advocacy is when people engage in the legislative process by sharing their views with their elected leaders.  It can take the form of writing or signing on to letters, testifying at hearings, attending town halls, visiting an elected leader at their office; or, here in Arizona, sharing their position on bills at the Legislature using the Request to Speak System. Continue reading